<DOC>
	<DOCNO>NCT02005302</DOCNO>
	<brief_summary>Multi-center , prospective , randomize , control study verify clinical effectiveness K / DOQI guideline . The efficiency safety Vitamin D2 low protein diet treatment prevention treatment CKD-MBD malnutrition CKD3-5 ( ND ) patient .</brief_summary>
	<brief_title>Optimizing Treatment Programs Chronic Kidney Disease-mineral Bone Disorder Malnutrition</brief_title>
	<detailed_description>This study enroll chronic kidney disease patient , stage 3 5ND , chronic kidney disease mineral bone disease ( CKD-MBD ) malnutrition define Kidney Disease Improvement Global Outcome ( KDIGO ) Guidelines . Patients five center randomize . A total 600 patient enrol , 150 patient receive Vitamin D2 treatment virus 150 patient receive calcitriol treatment , another 150 patient receive low protein diet virus 150 patient receive normal protein diet . Outcomes assessed proportion patient achieve target blood level calcium , phosphorus , parathyroid hormone , 25 hydroxyvitamin D , albumin hemoglobin . Other outcome also assess , include secondary hyperparathyroidism ( sHPT ) , vascular calcification , cardiovascular disease , nutritional status quality life .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Malnutrition</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Vitamin A</mesh_term>
	<criteria>Patients age 1880 year . Patients chronic kidney disease stage 3 5 , concurrent chronic kidney disease mineral bone disorder malnutrition Renal artery stenosis , inherent renal malformation , solitary kidney , malignancy urinary system . Active system immunity disease . History liver failure History intestinal malabsorption chronic diarrhea Treatment phenobarbital , phenytoin , rifampicin , sucralfate , steroid , digoxin , medication could affect vitamin D metabolism Primary hyperparathyroidism Treatment cinacalcet calcimimetic within past 6 month Anticipated dialysis within 6 month randomization Have unstable medical condition , define hospitalize within 30 day screen , expectation recurrent hospital admission life expectancy le 6 month judgment investigator Subject currently enrol , few 30 day pass since subject complete another investigational device drug study ( ) ; subject receive another investigational agent ( ) . Current treatment vitamin D 50,000 IU Using glucocorticoid immunosuppressive agent . Acute renal dysfunction . The expected live time le 2 year . Pregnant lactate woman . Suffered acute myocardial infraction , acute congestive heart failure , stroke last 6 month . Patients whose concurrent illness , disability , geographical residence would hamper attendance require study visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>chronic kidney disease</keyword>
	<keyword>mineral bone disease</keyword>
	<keyword>Malnutrition</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>low protein diet</keyword>
</DOC>